Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

December 1, 2024

Conditions
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell CarcinomasSquamous Cell Carcinoma of Head and NeckSquamous Cell Carcinoma of the SkinSquamous Cell Carcinoma of the Head and NeckSkin CancerHigh-Risk CancerQuality of LifeSatisfaction, Patient
Interventions
OTHER

Regular care with additionally administration of questionnaires

"Patients receiving regular care. In addition, validated questionnaires are administered at two measurement points:~1. after the multidisciplinary consultation, a baseline questionnaire\*, the decision conflict scale and the EQ-5D-5L questionnaire are administered by phone.~2. 1 month after completion of the treatment program (care pathway) the EQ-5D-5L, the BaSQoL and the EORTC IN-PATSAT32 questionnaires will be administered by phone.~Completing the questionnaires takes about 30 minutes each time.~\*Baseline questionnaire: gender, age, marital status, education level, World Health Organization (WHO) performance status, presence of informal care, stage and treatment of cSCC, history of skin cancer, presence of current other skin cancer, and average travel time to hospital."

Trial Locations (2)

Unknown

Radboud UMC, Nijmegen

Maastricht University Medical Center +, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER